SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical Systems


STOCKHOLM, June 9, 2021 /PRNewswire/ -- SyntheticMR announced today that they have entered a development project together with Juntendo University Hospital, based in Tokyo, Japan, and Canon Medical Systems. The project will focus on joint development and evaluation of quantitative MR imaging solutions for clinical practice.


For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87

This information was brought to you by Cision

The following files are available for download:

Press release SyntheticMR 09062021 EN

Cision View original content:


Company Codes: ISIN:SE0015987946, Stockholm:SYNT

Back to news